Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi Ambien patent

Executive Summary

Sanofi will list Ambien patent covering modified-release version of insomnia agent in FDA's "Orange Book," company says. Patent for zolpidem MR (no. 6,514,531) would run to 2019; Ambien exclusivity currently expires in 2006. Sanofi plans to file in 2004 for FDA approval (1"The Pink Sheet" Feb. 24, p. 15)...
Advertisement

Related Content

Sanofi Ambien Line Extension Planned For 2004; Still Confident In Arixtra   
Sanofi Ambien Line Extension Planned For 2004; Still Confident In Arixtra   
Advertisement
UsernamePublicRestriction

Register

PS041368

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel